Infectious Diseases News and Research

RSS

Bournemouth University helps organise health promotion conference in Nepal

Bournemouth University has helped organise the first National Health Promotion conference in Nepal.

30 Mar 2013

Medivir seeks FDA approval for simeprevir

Medivir AB today announced that a new drug application has been filed with the U.S. Food and Drug Administration seeking approval for simeprevir.

30 Mar 2013

Correctional policies discourage released inmates from seeking methadone therapy, researchers say

Methadone treatment for opioid dependence remains widely unavailable behind bars in the United States, and many inmates are forced to discontinue this evidence-based therapy, which lessens painful withdrawal symptoms.

30 Mar 2013

Viral protein hijacks cellular machinery and grabs the wheel

Northwestern Medicine scientists have identified a component of the herpesvirus that "hijacks" machinery inside human cells, allowing the virus to rapidly and successfully invade the nervous system upon initial exposure.

30 Mar 2013

New concept to fight microorganisms can promote stronger immune system

Managing bacteria and other microorganisms in the body, rather than just fighting them, may be lead to better health and a stronger immune system, according to a Penn State biologist.

29 Mar 2013

Inflammation and epigenetics: an interview with Dr Belkina and Dr Denis, Boston University School of Medicine

Inflammation can be thought of as taking two major forms: acute or chronic. Acute inflammation, which can be painful, usually arises quickly and resolves quickly. It accompanies bacterial infections, traumatic injury and is useful to fight infections and promote healing.

28 Mar 2013

Cases of new coronavirus rises to 17, number of deaths is 11

"The deadly and mysterious coronavirus that first appeared in Saudi Arabia last year has claimed two more victims, bringing the official death toll to 11," and the case count to 17, the Los Angeles Times' "Booster Shots" blog reports.

28 Mar 2013

CureVac begins CV9104 Phase 2b clinical trial in patients with castration-resistant prostate cancer

CureVac GmbH, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapies and vaccines based on messenger RNA, today announced that it has initiated a double-blind, randomized Phase 2b clinical trial of its RNActive cancer vaccine, CV9104, for the treatment of patients with castration-resistant prostate cancer.

28 Mar 2013

FDA accepts Merck's BLA for investigational Timothy grass pollen AIT

Merck, known as MSD outside the United States and Canada, today announced that the Biologics License Application for its investigational Timothy grass pollen (Phleum pratense) allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration.

28 Mar 2013

Researcher discovers genetic variations that are linked to breast cancer

Working with an international consortium conducting research on breast, ovarian and prostate cancer among 200,000 people, Professor Jacques Simard, holder of the Canada Research Chair in Oncogenetics at Laval University, was actively involved in the discovery of DNA "spelling mistakes" linked to breast cancer.

28 Mar 2013

Patients taking antihistamines to suppress stomach acid are at greater risk of C. diff infection

Patients receiving antihistamines to suppress stomach acid are at greater risk of infection from Clostridium difficile, or C. diff, a common cause of diarrhea, particularly in health care settings, Mayo Clinic researchers have found.

28 Mar 2013

Researchers examine performance of Africa's expanded programme on immunization

In a paper published in PLoS Medicine last week, researchers from the Vaccines for Africa Initiative at the University of Cape Town's Institute of Infectious Disease and Molecular Medicine examine the performance of the Expanded Programme on Immunization (EPI) in Africa since its inception in 1974.

27 Mar 2013

Microbiologists identify unique resistance mechanisms of E. coli to carbapenems

As public health authorities across the globe grapple with the growing problem of antibiotic resistance, Tufts University School of Medicine microbiologists and colleagues have identified the unique resistance mechanisms of a clinical isolate of E. coli resistant to carbapenems.

27 Mar 2013

FDA clears Soligenix's IND application for SGX942 for treatment of oral mucositis

Soligenix, Inc., a clinical stage biopharmaceutical company, announced today that the Food and Drug Administration has completed its review and cleared the Investigational New Drug application for SGX942 for the treatment of oral mucositis resulting from radiation and/or chemotherapy treatment in head and neck cancer patients.

27 Mar 2013

Lancet series examines tuberculosis

"To commemorate World TB Day 2013, the Lancet Infectious Diseases publishes a series of papers on tuberculosis, a disease that has long plagued human beings and was declared a global emergency in 1993 by WHO," the series homepage states.

27 Mar 2013

EMA accepts Shionogi's ospemifene MAA for treatment of VVA in post-menopausal women

Shionogi Limited, the London-based European subsidiary of Shionogi & Co., Ltd announced today that on 26th March 2013 the European Medicines Agency accepted its Marketing Authorisation Application submission for ospemifene for the treatment of vulvar and vaginal atrophy in post-menopausal women.

27 Mar 2013

Trovagene introduces urine-based HPV-HR DNA test for identifying high-risk HPV strains

Trovagene, Inc., today announced the commercial availability of its urine-based HPV-HR (high-risk) assay, a molecular human papillomavirus test.

27 Mar 2013

Research paper highlights implementation of infectious disease curriculum in Boston Public Schools

A research paper published online this month in Academic Medicine highlights the successful development, implementation, and effects of an infectious disease curriculum that has now been piloted in five Boston Public Schools.

27 Mar 2013

Focused approach needed to end TB

Addressing the question of whether the international community can eliminate tuberculosis, Arundhati Maitra and Sanjib Bhakta of the Department of Biological Sciences at the University of London write in an opinion piece in the AlertNet News Blog, "With an estimated 8.7 million reported cases and 1.4 million deaths due to TB in 2011, the question above poses one of the most serious challenges faced by the scientific community, health care industry, government and public organizations worldwide."

26 Mar 2013

Challenges remain in fight against TB, U.N. Secretary-General says

On World Tuberculosis Day, recognized on March 24, U.N. Secretary-General Ban Ki-moon "said that while there has been much progress since the World Health Organization declared TB a global health emergency two decades ago, there are still challenges to be met, mainly stopping the spread of multidrug-resistant TB, also known as MDR-TB, which threatens to reverse the gains achieved in past years," the U.N. News Centre reports.

26 Mar 2013

Infectious Diseases News and Research

Bournemouth University helps organise health promotion conference in Nepal

Medivir seeks FDA approval for simeprevir

Correctional policies discourage released inmates from seeking methadone therapy, researchers say

Viral protein hijacks cellular machinery and grabs the wheel

New concept to fight microorganisms can promote stronger immune system

Inflammation and epigenetics: an interview with Dr Belkina and Dr Denis, Boston University School of Medicine

Cases of new coronavirus rises to 17, number of deaths is 11

CureVac begins CV9104 Phase 2b clinical trial in patients with castration-resistant prostate cancer

FDA accepts Merck's BLA for investigational Timothy grass pollen AIT

Researcher discovers genetic variations that are linked to breast cancer

Patients taking antihistamines to suppress stomach acid are at greater risk of C. diff infection

Researchers examine performance of Africa's expanded programme on immunization

Microbiologists identify unique resistance mechanisms of E. coli to carbapenems

FDA clears Soligenix's IND application for SGX942 for treatment of oral mucositis

Lancet series examines tuberculosis

EMA accepts Shionogi's ospemifene MAA for treatment of VVA in post-menopausal women

Trovagene introduces urine-based HPV-HR DNA test for identifying high-risk HPV strains

Research paper highlights implementation of infectious disease curriculum in Boston Public Schools

Focused approach needed to end TB

Challenges remain in fight against TB, U.N. Secretary-General says

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News